RxDoctor Payments Data

Jonathan Pezanoski, MD

Gastroenterology · Reno, NVNPI 1053355545

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 37.0% of the total. 2025 is the largest year on record at $1,025, 2.2 times the $474 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in NV, where the typical reported total is $3,212.

$3,071in general payments, 2019–2025

Across 109 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Boston Scientific$627
  • Johnson & Johnson$266
  • Ipsen Biopharmaceuticals, Inc$189
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$111
  • Takeda Pharmaceuticals U.S.A., Inc.$110
  • plus $633 from 13 others

What the payments were for

  • Food & beverage$3,063100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,071 in reported general payments places this provider in the 45th percentile of 103 gastroenterology providers in Nevada.

See all gastroenterology providers in Nevada

Medicare billing

Part B allowed, 2024
$160,452
Medicare patients
597
Services billed
1,145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab13$85,314
Ursodiol21$4,850
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl160$2,766
Budesonide EcBudesonide14$1,943
Pantoprazole Sodium138$1,661
Omeprazole130$1,383
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl49$813
CholestyramineCholestyramine (With Sugar)11$626
Sucralfate34$596
Ondansetron OdtOndansetron15$372
Lidocaine Hcl ViscousLidocaine Hcl16$366
Dicyclomine Hcl21$305
Famotidine21$141
Metronidazole11$95

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →